The first Evolent Health trade was made in Q2 2017.
Since then Joel Greenblatt bought shares three more times and sold shares on two occasions. The investor sold all their shares in Q4 2022 and doesn't own any shares in Evolent Health anymore.
Avg closing price
Price range
Sold -24.5 Thousand shares
Q4 2022
Avg closing price
$28.67
Price range
$21.96
-
$37.41
Increased shares by 46.5% (+7.79 Thousand shares)
Q3 2022
Avg closing price
$35.23
Price range
$29.37
-
$39.74
Increased shares by 136.2% (+9.66 Thousand shares)
Q2 2022